A Phase 1/2 Trial of ADI-270 in ccRCC

NCT06480565 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma

Interventions

DRUG: ADI-270
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Adicet Therapeutics